A Simple Blood Test May Help Predict Risk of Death in Kidney Failure

Dialysis helps people with kidney failure stay alive. But even with dialysis, many patients die sooner than expected. Doctors have struggled to figure out who is most at risk. A new study from Karolinska Institutet in Sweden found that a simple blood test might help. This test looks at the balance between two groups of amino acids — the building blocks of protein. When this balance is off, patients had a 74% higher chance of dying within five years. The study followed 328 patients and was published in April 2026 in the journal Scientific Reports.

Why Dialysis Patients Still Face High Risks

Patients on dialysis die at much higher rates than the general population — sometimes 10 to 30 times higher. The main causes are heart problems, infections, and the body slowly breaking down. Doctors already check many things like blood pressure, inflammation, and nutrition. But even with all these tests, it has been hard to predict who is in the most danger. The Karolinska team decided to look at amino acids because the kidneys normally help balance these chemicals. When kidneys fail, amino acid levels get messy. But looking at just one amino acid didn't help. So they looked at the relationship between two groups.

What the Study Found: A 74% Higher Risk

The researchers took blood samples from 328 kidney failure patients at the start of their dialysis. Then they followed them for five years. The results were clear: patients with a low Fischer's ratio had a 74% higher risk of dying compared to patients with a healthy ratio. That's a big difference. Even more striking: when they looked only at patients who also had heart disease, those with a low ratio had more than four times the risk of death. The test worked even after accounting for other factors like age, diabetes, and inflammation levels.

Why the Balance Matters More Than Single Numbers

Here is the interesting part. When the scientists looked at each group of amino acids by itself — just the BCAAs or just the aromatic amino acids — neither one predicted death. The signal only appeared when they looked at the balance between them. That's why Fischer's ratio is special. It captures two problems at once: low BCAAs suggest the body is breaking down muscle (a sign of poor nutrition). High aromatic amino acids suggest the liver is stressed and the body has inflammation. Together, these two problems create a perfect storm. Neither one alone tells the full story. The ratio does.

What This Means for Patients Today

The good news is that this test is not new, fancy, or expensive. It uses a standard blood draw and a machine called a liquid chromatograph, which most hospital labs already have. That means if larger studies confirm these findings, doctors could start using Fischer's ratio as a routine test for dialysis patients. Patients with a low ratio might need extra nutritional support, closer heart monitoring, or more frequent check-ups. The effect was strongest in patients who already had heart disease — in that group, a low ratio meant four times the risk. There was also a similar trend in diabetic patients, though the numbers were not large enough to be certain.

What We Still Don't Know

The study is promising, but it has limits. It was done at just one hospital in Sweden, so we don't know if the results apply to other countries or populations. The test was done only once, at the start of dialysis. We don't know if a patient's ratio changes over time, or if improving the ratio through diet or supplements would actually help them live longer. The study also didn't track what patients ate, even though food directly affects amino acid levels. Despite these limits, the study is important because it shows a clear signal. Now researchers need to do larger studies, measure the ratio multiple times, and eventually test whether fixing the ratio helps patients live longer.

• The ratio is smarter than single numbers — Neither group of amino acids alone could predict death. Only the balance between them worked.
• Heart patients need the most attention — If you have both kidney failure and heart disease, a low Fischer's ratio is a very strong warning sign.
• The test is already available — Most hospitals have the equipment to run this test. No new machines are needed.

"The warning signal from Fischer's ratio was strongest in patients with heart disease. This tells us we need to study more about how amino acid balance connects to heart health in kidney patients." — Zhang, Suliman, Qureshi et al., Scientific Reports, 2026.

Advertisement